EventsThe 2nd International Conference on Bioengineering
Published
This submission belongs to the session S4. Biomedical Engineering and Biomaterials of the event The 2nd International Conference on Bioengineering
Published date
16 Nov, 2026
Citation
Zhenqiang Shi, Specific Biomolecular Recognition Toward Bioseparation and Detection, in Proceedings of The 2nd International Conference on Bioengineering, Barcelona, 10 November–13 November 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Specific Biomolecular Recognition Toward Bioseparation and Detection

1. School of Bioengineering, Dalian University of Technology, China
Abstract

Biomolecular recognition, defined by high‑affinity and selective interactions between a ligand and its target, forms the cornerstone of modern bioseparation and biodetection technologies. From affinity chromatography and targeted therapy to point‑of‑care diagnostics, the ability to discriminate a target molecule within a complex biological matrix dictates the sensitivity, selectivity, and overall performance of these systems. To overcome the intrinsic limitations of natural bioreceptors, our research centers on precision ligand design, integrating rational molecular design, phage‑display screening, and AI‑assisted engineering to systematically enhance both selectivity and affinity toward clinically relevant biotargets.

We have developed ligands against a broad spectrum of biotargets, including endotoxins, inflammatory cytokines, cancer markers, and viral antigens. A representative success is a peptide‑based bottlebrush polymer designed for the specific clearance of lipopolysaccharide (LPS) from blood. This material removes >70% of LPS in septic models and reverses organ damage, a direct consequence of the high selectivity and sub‑nanomolar affinity engineered into the peptide ligand. Beyond sepsis, our platform enables cross‑scale recognition from sub‑nanometer proteins and polysaccharides to micron‑sized tumor cells, while maintaining excellent hemocompatibility and minimal nonspecific adsorption.

Developed in collaboration with leading hospitals, these materials are advancing toward clinical translation. Collectively, our work demonstrates that precision ligand design is the decisive factor for achieving specific biomolecular recognition with the requisite selectivity and affinity for demanding bioseparation and detection applications, offering a versatile and translatable solution for precision medicine.

Keywords
biomolecular interaction
separation
detection
precision medicine
Engineering a Synthetic Microbial Consortium for Efficient Heavy Oil Degradation and Viscosity Reduction
Optimising Correction of Craniosynostosis Through Advanced Digital Technologies